Literature DB >> 17848280

Robotic anterior and midline skull base surgery: preclinical investigations.

Bert W O'Malley1, Gregory S Weinstein.   

Abstract

PURPOSE: To develop a minimally invasive surgical technique to access the midline and anterior skull base using the optical and technical advantages of robotic surgical instrumentation. METHODS AND MATERIALS: Ten experimental procedures focusing on approaches to the nasopharynx, clivus, sphenoid, pituitary sella, and suprasellar regions were performed on one cadaver and one live mongrel dog. Both the cadaver and canine procedures were performed in an approved training facility using the da Vinci Surgical Robot. For the canine experiments, a transoral robotic surgery (TORS) approach was used, and for the cadaver a newly developed combined cervical-transoral robotic surgery (C-TORS) approach was investigated and compared with standard TORS. The ability to access and dissect tissues within the various areas of the midline and anterior skull base were evaluated, and techniques to enhance visualization and instrumentation were developed.
RESULTS: Standard TORS approaches did not provide adequate access to the midline and anterior skull base; however, the newly developed C-TORS approach was successful in providing the surgical access to these regions of the skull base.
CONCLUSION: Robotic surgery is an exciting minimally invasive approach to the skull base that warrants continued preclinical investigation and development.

Entities:  

Mesh:

Year:  2007        PMID: 17848280     DOI: 10.1016/j.ijrobp.2007.06.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Morphometric measurements of the anterior skull base for endoscopic transoral and transnasal approaches.

Authors:  Bradley C Lega; Daniel R Kramer; Jason G Newman; John Y K Lee
Journal:  Skull Base       Date:  2011-01

2.  Load evaluation of the da Vinci surgical system for transoral robotic surgery.

Authors:  Kazunori Fujiwara; Takahiro Fukuhara; Koji Niimi; Takahiro Sato; Hiroya Kitano
Journal:  J Robot Surg       Date:  2015-10-17

3.  Transoral robotic surgery of the central skull base: preclinical investigations.

Authors:  F J J Fernandez-Nogueras; M J Katati; M A Arraez Sanchez; M Molina Martinez; M Sanchez Carrion
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

4.  Computer modeled multiportal approaches to the skull base.

Authors:  Randall A Bly; David Su; Blake Hannaford; Manuel Ferreira; Kris S Moe
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-16

5.  Multiportal robotic access to the anterior cranial fossa: a surgical and engineering feasibility study.

Authors:  Randall A Bly; David Su; Thomas S Lendvay; Diana Friedman; Blake Hannaford; Manuel Ferreira; Kris S Moe
Journal:  Otolaryngol Head Neck Surg       Date:  2013-10-23       Impact factor: 3.497

6.  DaVinci robot-assisted transcervical excision of a parapharyngeal space tumor.

Authors:  David Goldenberg; Michael P Ondik
Journal:  J Robot Surg       Date:  2010-07-24

Review 7.  Endoscopic endonasal skull base surgery: past, present and future.

Authors:  Paolo Castelnuovo; Iacopo Dallan; Paolo Battaglia; Maurizio Bignami
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-09       Impact factor: 2.503

8.  Robotic surgery in ear nose and throat.

Authors:  Amit Parmar; David G Grant; Peter Loizou
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-06-27       Impact factor: 2.503

9.  [Initial experience with transoral robotic surgery using the da Vinci® surgical system].

Authors:  C Simon; B El-Baba; T Albrecht; F C Holsinger; P K Plinkert
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

10.  Combined transoral transnasal robotic-assisted nasopharyngectomy: a cadaveric feasibility study.

Authors:  Iacopo Dallan; Paolo Castelnuovo; Filippo Montevecchi; Paolo Battaglia; Niccolò Cerchiai; Veronica Seccia; Claudio Vicini
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-18       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.